HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Controversial issues regarding general anesthesia for cesarean section].

Abstract
Although, general anesthesia for cesarean section still seems to be the method of choice in extremely urgent settings, past anesthetic evidence has shown that general anesthesia is with increased risk of anesthesia-related maternal mortality. The major disadvantage with general anesthesia is the risk of aspiration of gastric contents and a "cannot ventilate, cannot intubate" situation. Awareness is another concern. There has been a decrease in the number of cesarean section performed under general anesthesia, and a progress in the management of aspiration of gastric contents and difficult airway. This review examines the recent knowledge of these topics. We also describe the benefits and risks of new drugs, such as propofol, remifentanil and rocuronium in general anesthesia for cesarean section.
AuthorsHiroshi Ueyama
JournalMasui. The Japanese journal of anesthesiology (Masui) Vol. 59 Issue 3 Pg. 357-61 (Mar 2010) ISSN: 0021-4892 [Print] Japan
PMID20229754 (Publication Type: Journal Article, Review)
Chemical References
  • Androstanols
  • Piperidines
  • Remifentanil
  • Rocuronium
  • Propofol
Topics
  • Androstanols
  • Anesthesia, General (adverse effects)
  • Anesthesia, Obstetrical (adverse effects)
  • Cesarean Section
  • Female
  • Humans
  • Intraoperative Care
  • Intubation, Intratracheal
  • Piperidines
  • Pregnancy
  • Propofol
  • Remifentanil
  • Respiratory Aspiration (etiology, prevention & control)
  • Risk
  • Rocuronium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: